2[1]Bleiberg H. Oxaliplatin(L-OHP): a new reality in colorectal cancer [J]. Br J Cancer, 1998,77(Suppl 4):1-5.
3[2]Becouarn Y, Rougier P. Clinical efficacy of oxaliplatin monotherapy: phase Ⅱ trials in advanced colorectal cancer[J]. Semin Oncol, 1998, 25(Suppl):23-27.
4[3]Artru P, Andre T, Tigaud JM, et al. Oxaliplatin(OXA), 5 Fluorouracil (Fu) and Folrinic acid (FA) (Folfox6) in advanced metastatic gastric carcinoma(AMGC) patients: final results of a multicenter phase Ⅱ study [J]. Pro ASCO,2001, 20:165a(abstr 654).
5[4]Maindrault-Goebel F, de gramont A, Louvet C, et al. High dose intencity Oxaliplatin added to the simplified bimonthly leuvorin and 5-florouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX7) [J]. Eur J Cancer, 2001, 37(8):1000-1005.
6[5]Degramant A, Louvet C, Andre T, et al. A review of GER COD trials of bimonthly leucovorin plus 5-florouracil 48 hour continuous infusion in advanced colorectal cancer: evalution of a regimen[J]. Eur J Cancer, 1998, 34(5): 619 -626.
